197 related articles for article (PubMed ID: 25653529)
1. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.
Novick D; Hong J; Montgomery W; Dueñas H; Gado M; Haro JM
Neuropsychiatr Dis Treat; 2015; 11():197-205. PubMed ID: 25653529
[TBL] [Abstract][Full Text] [Related]
2. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Asia Pac Psychiatry; 2016 Mar; 8(1):51-9. PubMed ID: 25808275
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Patient Prefer Adherence; 2015; 9():1481-90. PubMed ID: 26527865
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline.
Huang J; Wang Y; Chen J; Zhang Y; Yuan Z; Yue L; Haro JM; Moneta MV; Novick D; Fang Y
Neuropsychiatr Dis Treat; 2018; 14():2473-2484. PubMed ID: 30310285
[TBL] [Abstract][Full Text] [Related]
5. Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Novick D; Montgomery W; Haro JM; Moneta MV; Zhu G; Yue L; Hong J; Dueñas H; Brugnoli R
Neuropsychiatr Dis Treat; 2016; 12():383-92. PubMed ID: 26966361
[TBL] [Abstract][Full Text] [Related]
6. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
[TBL] [Abstract][Full Text] [Related]
7. Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study.
Novick D; Montgomery W; Vorstenbosch E; Moneta MV; Dueñas H; Haro JM
Patient Prefer Adherence; 2017; 11():1859-1868. PubMed ID: 29184393
[TBL] [Abstract][Full Text] [Related]
8. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
[TBL] [Abstract][Full Text] [Related]
9. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
10. Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.
Hong J; Novick D; Moneta MV; El-Shafei A; Dueñas H; Haro JM
Clin Pract Epidemiol Ment Health; 2017; 13():145-155. PubMed ID: 29238391
[TBL] [Abstract][Full Text] [Related]
11. The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): a psychometric analysis in a clinical sample.
Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Alvarez E; Pérez V; Portella MJ
J Affect Disord; 2014 Dec; 169():189-96. PubMed ID: 25212994
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
14. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
16. Looking into the effect of multi-item symptom domains on psychometric characteristics of the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR
Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Álvarez E; Pérez V; Portella MJ
Psychiatry Res; 2018 Sep; 267():126-130. PubMed ID: 29890375
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care.
Cameron IM; Crawford JR; Cardy AH; du Toit SW; Lawton K; Hay S; Mitchell K; Sharma S; Shivaprasad S; Winning S; Reid IC
J Psychiatr Res; 2013 May; 47(5):592-8. PubMed ID: 23419617
[TBL] [Abstract][Full Text] [Related]
18. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AW
Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
[TBL] [Abstract][Full Text] [Related]
19. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
